Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 67 (2017): Issue 1 (March 2017)
Open Access
The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
Xin Sun
Xin Sun
,
Yan Zhang
Yan Zhang
and
Meilin Xie
Meilin Xie
| Feb 21, 2017
Acta Pharmaceutica
Volume 67 (2017): Issue 1 (March 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Review
Published Online:
Feb 21, 2017
Page range:
1 - 13
Accepted:
Oct 06, 2016
DOI:
https://doi.org/10.1515/acph-2017-0007
Keywords
non alcoholic fatty liver disease
,
peroxisome proliferator activated receptors
,
agonists
,
insulin resistance
,
inflammation
© by Yan Zhang
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Xin Sun
Department of Pharmacy Wuxi No. 2 People´s Hospital The Affiliated Hospital of Nanjing Medical University
Wuxi, China
Yan Zhang
Department of Gynecology and Obstetrics, Wuxi Maternal and Child Health Hospital, The Affiliated Hospital of Nanjing Medical University
Wuxi, China
Department of Pharmacology College of Pharmaceutical Sciences Soochow University
Suzhou, China
Meilin Xie
Department of Pharmacology College of Pharmaceutical Sciences Soochow University
Suzhou, China